Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development
Leigh C. Walker(Florey Institute of Neuroscience and Mental Health), Andrew J. Lawrence(Florey Institute of Neuroscience and Mental Health), Howard C. Becker(Medical University of South Carolina), Christopher J. Langmead(Australian Regenerative Medicine Institute), Kade L. Huckstep(The University of Melbourne)
Cited by 15
Related Papers
Chronic voluntary alcohol consumption causes persistent cognitive deficits and cortical cell loss in a rodent model
|Scientific Reports|2019|313
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
|Pharmacological Reviews|2014|236
Role of cues and contexts on drug‐seeking behaviour
|British Journal of Pharmacology|2014|129
Community outbreak of hemolytic uremic syndrome attributable to Escherichia Coli O111:NM - South Australia, 1995
|Adelaide Research & Scholarship (AR&S) (University of Adelaide)|1995|102
Anterior Insular Cortex is Critical for the Propensity to Relapse Following Punishment-Imposed Abstinence of Alcohol Seeking
|Journal of Neuroscience|2018|77